Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 6, 2024; 12(16): 2704-2712
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2704
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2704
Figure 1 Viral entry activates immune responses in host cells, which can further be target using therapeutic agents or immunotherapy strategies for treating coronavirus disease 2019 infections.
ACE2: Angiotensin-converting enzyme 2; COVID-19: Coronavirus disease 2019; RBD; Receptor binding domain.
- Citation: Wu J, Zheng Y, Zhang LN, Gu CL, Chen WL, Chang MQ. Advanced nanomedicines and immunotherapeutics to treat respiratory diseases especially COVID-19 induced thrombosis. World J Clin Cases 2024; 12(16): 2704-2712
- URL: https://www.wjgnet.com/2307-8960/full/v12/i16/2704.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i16.2704